Hoth Therapeutics Inc (HOTH)
1.20
+0.01
(+0.84%)
USD |
NASDAQ |
Apr 19, 15:35
Hoth Therapeutics Cash from Financing (TTM): 11.32M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.32M |
September 30, 2023 | 11.37M |
June 30, 2023 | 8.962M |
March 31, 2023 | 14.95M |
December 31, 2022 | 6.036M |
September 30, 2022 | 5.985M |
June 30, 2022 | 5.885M |
March 31, 2022 | -0.2367M |
December 31, 2021 | 18.19M |
September 30, 2021 | 18.19M |
June 30, 2021 | 18.29M |
Date | Value |
---|---|
March 31, 2021 | 22.93M |
December 31, 2020 | 8.725M |
September 30, 2020 | 8.725M |
June 30, 2020 | 10.34M |
March 31, 2020 | 5.824M |
December 31, 2019 | 7.450M |
September 30, 2019 | 7.450M |
June 30, 2019 | 5.809M |
March 31, 2019 | 5.826M |
December 31, 2018 | 1.155M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-0.2367M
Minimum
Mar 2022
22.93M
Maximum
Mar 2021
10.33M
Average
8.725M
Median
Sep 2020
Cash from Financing (TTM) Benchmarks
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |
Asensus Surgical Inc | 9.626M |
Myomo Inc | 9.714M |